Ripertamab (Anti-CD20)
Ripertamab (Anti-CD20) is a chimeric monoclonal antibody directed against human CD20 with potential antineoplastic activity. MW : 144.56 KD.
Trivial name | SCT400 |
Catalog Number | A2805 |
CAS# | 2249927-04-4 |
Size | 1mg*5 |
Ripertamab (Anti-CD20) is a chimeric monoclonal antibody directed against human CD20 with potential antineoplastic activity. MW : 144.56 KD.
Trivial name | SCT400 |
Catalog Number | A2805 |
CAS# | 2249927-04-4 |
Size | 1mg*5 |